Loading: 100%
AMERISOURCEBERGEN CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 19,000 (as per Q3 2017)no data available
Sector Medical Distribution, HealthcareMedical Distribution, Healthcareno data available
Ticker ABCno data available
Financial year endsFY ends End of Septemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1760708090100
datesClosing price (adj.)
13.10.201779.44
11.10.201780.32
04.10.201782.74
27.09.201782.43
20.09.201779.50
13.09.201784.32
06.09.201780.72
30.08.201778.33
23.08.201778.14
16.08.201779.67
09.08.201779.44
02.08.201790.86
26.07.201793.78
19.07.201790.76
12.07.201792.79
05.07.201794.79
27.06.201795.10
20.06.201792.83
13.06.201792.58
06.06.201791.27
30.05.201790.62
23.05.201788.78
16.05.201788.34
09.05.201786.78
02.05.201781.94
25.04.201780.80
18.04.201781.84
11.04.201787.10
04.04.201786.17
28.03.201786.74
21.03.201785.16
14.03.201788.04
07.03.201787.71
28.02.201790.71
21.02.201790.22
14.02.201789.67
07.02.201789.18
31.01.201786.17
24.01.201783.34
17.01.201784.90
10.01.201783.75
03.01.201781.56
27.12.201677.82
19.12.201677.42
12.12.201677.08
05.12.201678.53
28.11.201678.05
21.11.201677.45
14.11.201679.93
07.11.201670.69
31.10.201669.11
24.10.201678.66
17.10.201678.37
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
79.44n/a
Market Capitalisation
in million USD
17,406n/a
Enterprise Value
in million USD
19,881n/a
Common Shares Outstanding
as per Jul 31, 2017
219,111,565n/a
Preferred Shares Outstanding
as per Jul 31, 2017
n/a
Average Basic Shares Outstanding
TTM
218,526,500n/a
Average Diluted Shares Outstanding
TTM
222,990,000n/a
Index Membership
n/a
Business Summary
AmerisourceBergen Corp is a pharmaceutical services company. It provides drug distribution and related healthcare services and solutions to pharmacy, physician, and manufacturer customers based in the United States and Canada.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 151,584n/a
Gross Profit 4,499n/a
Operating Income 1,752n/a
EBITDA 0n/a
Net Profit 855n/a
Balance Sheet
Cash and Cash Equivalents 1,311n/a
Receivables 10,553n/a
Total Current Assets 23,677n/a
PP&E 1,750n/a
Total Assets 34,654n/a
Accounts Payable 24,805n/a
Current Debt 4n/a
Total Current Liabilities 25,751n/a
Long-Term Debt 3,782n/a
Total Liabilities 32,100n/a
Total Equity 2,554n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 3.0%n/a
Operating Margin 1.2%n/a
Net Profit Margin 0.6%n/a
Return on Equity 33.5%n/a
Return on Assets 2.5%n/a
Per Share Figures
Basic EPS 3.91n/a
Diluted EPS 3.83n/a
Sales per Share 693.67n/a
Book Value per Share 11.69n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio 20.31n/a
Price to Sales Ratio 0.11n/a
Price to Book Value 6.80n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 0.13n/a
Book to Market Value 0.15n/a
Other Ratios
Current Ratio 92.0%n/a
Liabilities to Equity Ratio 1,257.1%n/a
Debt to Assets Ratio 10.9%n/a
Profit & Loss StatementP&L data quality: 58% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
65,672
70,190
71,760
77,776
78,696
78,081
87,959
119,569
135,962
146,850
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
0
Cost of revenue
-63,453
-68,143
-69,660
-75,451
-76,237
-75,446
-85,451
-116,587
-132,432
-142,577
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
2,219
2,047
2,100
2,325
2,459
2,635
2,508
2,982
3,529
4,273
Other Operating Income
0
0
0
0
0
0
0
0
0
0
Operating Expenses
-1,425
-1,201
-1,199
-1,234
-1,239
-1,287
-1,586
-2,192
-3,069
-2,596
Selling, General & Administrative
-1,340
-1,119
-1,120
-1,151
-1,138
-1,153
-1,334
-1,581
-1,908
-2,091
Selling & Marketing
0
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
-85
-82
-79
-84
-101
-134
-162
-189
-249
-365
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
-90
-423
-913
-140
Operating Income (Loss)
794
846
901
1,091
1,220
1,348
922
790
460
1,676
Non-Operating Income (Loss)
29
62
-60
-76
-72
-87
-74
-79
-123
-135
Interest Expense, net
32
64
-58
-72
-76
-93
-74
-84
-109
-140
Interest Expense
0
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-3
-2
-1
-3
5
6
0
4
-14
5
Pretax Income (Loss), Adjusted
824
908
841
1,015
1,148
1,261
848
711
337
1,541
Abnormal Gains (Losses)
-6
-5
-17
1
-30
-44
-23
-41
-69
-151
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
818
903
824
1,016
1,118
1,217
824
670
269
1,391
Income Tax (Expense) Benefit, net
-279
-292
-312
-386
-420
-456
-331
-388
-407
37
Current Income Tax
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
539
610
512
630
697
761
493
282
-138
1,428
Net Extraordinary Gains (Losses)
-6
0
-8
7
9
-42
-60
-8
0
0
Discontinued Operations
-6
0
-8
7
9
-42
-60
-8
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
534
610
503
637
707
719
434
274
-138
1,428
Minority Interest
0
0
0
0
0
0
0
0
0
0
Net Income
534
610
503
637
707
719
434
274
-138
1,428
Preferred Dividends
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
534
610
503
637
707
719
434
274
-138
1,428
Remarks
restated on Nov 25, 2009 n/a
calculated values,
restated on Nov 23, 2010 n/a
calculated values,
restated on Nov 22, 2011 n/a
calculated values,
restated on Nov 27, 2012 n/a
calculated values,
restated on Nov 26, 2013 n/a
calculated values,
restated on Nov 25, 2014 n/a
calculated values,
restated on Nov 24, 2015 n/a
calculated values,
restated on Nov 22, 2016 n/a
calculated values,
restated on Nov 22, 2016 n/a
calculated values,
restated on Nov 22, 2016 n/a
calculated values,
Balance SheetBS data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
878
1,009
1,658
1,826
1,067
1,231
1,809
2,167
2,742
Cash & Cash Equivalents
n/a
878
1,009
1,658
1,826
1,067
1,231
1,809
2,167
2,742
Short Term Investments
n/a
0
0
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
3,480
3,917
3,827
3,794
3,785
6,052
6,313
8,223
9,176
Accounts Receivable, Net
n/a
3,480
3,917
3,827
3,794
3,785
6,052
6,313
8,223
9,176
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
0
Inventories
n/a
4,212
4,973
5,210
5,443
5,472
6,981
8,594
9,755
10,724
Raw Materials
n/a
0
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
100
55
53
312
735
129
85
189
210
Prepaid Expenses
n/a
56
55
53
87
72
129
85
189
210
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
44
0
0
225
663
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
0
Total Current Assets
n/a
8,670
9,954
10,748
11,375
11,058
14,394
16,800
20,334
22,852
Property, Plant & Equipment, Net
n/a
552
1,427
712
673
744
804
900
1,193
1,531
Property, Plant & Equipment
n/a
933
1,023
1,185
1,158
1,300
1,471
1,692
2,143
2,617
Accumulated Depreciation
n/a
-381
404
-474
-485
-556
-668
-793
-950
-1,086
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
2,996
3,000
2,975
2,935
3,640
3,721
3,832
6,436
9,255
Intangible Assets
n/a
0
0
0
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
0
4,144
5,991
Other Intangible Assets
n/a
2,875
2,859
2,845
2,806
3,523
3,500
3,482
1,993
2,968
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
121
141
129
129
117
222
351
298
296
Total Noncurrent Assets
n/a
3,548
4,427
3,686
3,608
4,384
4,525
4,732
7,628
10,786
Total Assets
n/a
12,218
14,381
14,435
14,983
15,442
18,919
21,532
27,963
33,638
Liabilities and owners' equity
Payables & Accruals
n/a
7,597 7597403000
8,833 8832819000
9,202 9202301000
9,602 9601919000
10,063 10062799000
13,868 13868356000
16,155 16154697000
21,578 21578227000
24,670 24670159000
Accounts Payable
n/a
7,327 7326580000
8,517 8517162000
8,833 8833285000
9,191 9191428000
9,493 9492589000
13,336 13335792000
15,593 15592834000
20,886 20886439000
23,926 23926320000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
271 270823000
316 315657000
369 369016000
410 410491000
570 570210000
533 532564000
562 561863000
692 691788000
744 743839000
Short Term Debt
n/a
2 1719000
1 1068000
0 422000
392 392089000
0 0
0 0
0 0
0 0
610 610210000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
568 568467000
646 645723000
704 703621000
881 881256000
1,203 1202787000
1,002 1002279000
1,095 1095463000
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
551 550708000
646 645723000
704 703621000
839 838718000
963 963081000
1,002 1002279000
1,095 1095463000
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
18 17759000
0 0
0 0
43 42538000
240 239706000
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
8,168 8167589000
9,480 9479610000
9,906 9906344000
10,875 10875264000
11,266 11265586000
14,871 14870635000
17,250 17250160000
21,578 21578227000
25,280 25280369000
Long Term Debt
n/a
1,187 1187412000
1,177 1176933000
1,343 1343158000
973 972863000
1,396 1395931000
1,397 1396606000
1,996 1995632000
3,739 3739225000
3,852 3852484000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
153 152740000
200 199728000
231 231044000
268 267686000
326 325897000
332 331652000
329 329492000
2,029 2029144000
2,375 2375244000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
241 241205000
1,944 1944240000
2,215 2214774000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
153 152740000
200 199728000
231 231044000
268 267686000
326 325897000
332 331652000
88 88287000
85 84904000
160 160470000
Total Noncurrent Liabilities
n/a
1,340 1340152000
1,377 1376661000
1,574 1574202000
1,241 1240549000
1,722 1721828000
1,728 1728258000
2,325 2325124000
5,768 5768369000
6,228 6227728000
Total Liabilities
n/a
9,508 9507741000
10,856 10856271000
11,481 11480546000
12,116 12115813000
12,987 12987414000
16,599 16598893000
19,575 19575284000
27,347 27346596000
31,508 31508097000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
3,694 3694429000
3,743 3742664000
3,904 3904279000
4,088 4087943000
2,255 2255095000
2,364 2363670000
2,752 2751896000
3,739 3739227000
4,336 4335779000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-3,447 -3446972000
3,900 3899859000
-4,373 -4373332000
-5,226 -5225881000
-1,038 -1038019000
-1,517 -1516856000
-2,313 -2313380000
-4,151 -4150997000
-4,396 -4396008000
Retained Earnings
n/a
2,479 2479078000
2,920 2919760000
3,466 3465886000
4,056 4055664000
1,270 1270423000
1,508 1508414000
1,570 1570429000
1,164 1164489000
2,304 2303941000
Other Equity
n/a
-16 -16490000
-46 -46096000
-43 -42536000
-51 -50868000
-33 -32657000
-35 -35483000
-52 -52046000
-136 -136333000
-114 -114308000
Equity Before Minority Interest
n/a
2,710 2710045000
10,516 10516187000
2,954 2954297000
2,867 2866858000
2,455 2454842000
2,320 2319745000
1,957 1956899000
616 616386000
2,129 2129404000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
2,710 2710045000
10,516 10516187000
2,954 2954297000
2,867 2866858000
2,455 2454842000
2,320 2319745000
1,957 1956899000
616 616386000
2,129 2129404000
Total Liabilities & Equity
n/a
12,218 12217786000
21,372 21372458000
14,435 14434843000
14,983 14982671000
15,442 15442256000
18,919 18918638000
21,532 21532183000
27,963 27962982000
33,638 33637501000
Remarks restated on n/a restated on Nov 25, 2009 n/a restated on Nov 23, 2010 n/a restated on Nov 22, 2011 n/a restated on Nov 27, 2012 n/a restated on Nov 26, 2013 n/a restated on Nov 25, 2014 n/a restated on Nov 24, 2015 n/a restated on Nov 22, 2016 n/a restated on Aug 3, 2017 n/a
Cash Flow StatementCF data quality: 40% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
950
938
1,024
1,260
1,395
1,523
987
564
-276
2,856
Net Income
0
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
98
96
94
90
107
141
171
197
256
392
Non-Cash Items
89
122
160
174
267
101
176
905
1,577
330
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
546
33
25
190
106
414
-138
89
2,227
1,028
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
17
-7
25
-9
-112
86
-8
0
0
Cash from Operating Activities
1,683
1,206
1,296
1,738
1,865
2,067
1,282
1,746
3,784
4,606
Change in Fixed Assets & Intangibles
-98
-132
-146
-176
-155
-133
-202
-264
-232
-465
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-400
467
0
0
0
0
0
0
-86
60
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-86
-169
-1
0
-45
-776
330
-127
-2,616
-2,750
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
1
7
3
-14
Net Cash From Discontinued Operations (investing)
-91
-2
-1
-8
-12
-39
-12
0
0
0
Cash from Investing Activities
-674
163
-148
-184
-212
-948
117
-384
-2,931
-3,169
Dividends Paid
-37
-49
-63
-91
-118
-133
-196
-214
-254
-288
Cash From (Repayment of) Debt
227
-16
-9
179
0
52
0
566
1,496
713
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-1,340
-595
-428
-338
-685
-1,047
-328
-626
-1,665
169
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
0
Other Financing Activities
-4
-2
-4
-10
-7
-11
-166
-229
-209
-29
Net Cash From Discontinued Operations (financing)
0
0
0
-16
22
22
-51
0
0
0
Cash from Financing Activities
-1,155
-663
-504
-275
-788
-1,117
-741
-503
-632
565
Net Cash Before Disc. Operations and FX
-146
707
643
1,279
865
2
658
859
221
2,002
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-146
707
643
1,279
865
2
658
859
221
2,002
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
Net Changes in Cash
-146
707
643
1,279
865
2
658
859
221
2,002
Remarks
restated on Nov 25, 2009 n/a
calculated values,
restated on Nov 23, 2010 n/a
calculated values,
restated on Nov 22, 2011 n/a
calculated values,
restated on Nov 27, 2012 n/a
calculated values,
restated on Nov 26, 2013 n/a
calculated values,
restated on Nov 25, 2014 n/a
calculated values,
restated on Nov 24, 2015 n/a
calculated values,
restated on Nov 22, 2016 n/a
calculated values,
restated on Nov 22, 2016 n/a
calculated values,
restated on Nov 22, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo